Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore wealth mindset tips and strategies that can help you build wealth smartly. Start applying these techniques for success!
28,655 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
New surveys reveal a sharp contrast: americans trust financial advice from employers, yet a growing share doubt they’...
Debt worries surround a proposed $1.5 trillion boost to the Pentagon budget, drawing pushback from fiscal hawks and r...
CoreWeave is set to report Q4 2025 results after the close, with investors weighing 2026 guidance amid a legal backdr...
Buyers who wait for the perfect dip in housing are facing rising rents and missed appreciation. This report breaks do...
The IRS is proposing electronic delivery of Form 1099-DA for digital asset trades, with exchanges potentially termina...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Hong Kong’s RedotPay is exploring a fundraising round of up to $150 million ahead of a potential U.S. IPO, according ...
A fresh flare in Middle East tensions pushes oil prices higher, elevating Russia’s revenue outlook and prompting inve...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
OKX is close to purchasing a 20% stake in Coinone, a leading South Korean crypto exchange. The deal, still under regu...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...